Thanks for the added color. Did you make anything of Dr. Diab's comments about academic centers managing AE's better and getting higher responses or is that a generalization that can be applied to most new immuno-oncology therapies?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.